Latest Capital Raising News

Vertex Minerals has raised A$3.9 million through new share issuance, advancing its A$11 million capital raising to support the restart of its Hill End Gold Project amid strong gold prices.

Diablo Resources advances exploration at its Phoenix Copper Project with significant rock sampling results and drill permits granted for key prospects, setting the stage for drilling in Q3 2025.

Trek Metals has accelerated its exploration at the Christmas Creek Project with expanded drilling revealing promising high-grade gold mineralisation and a newly discovered gold nugget field. Backed by a $3.5 million capital raise and government co-funding, the company is poised for further breakthroughs.

Chariot Corporation has secured a 66.7% stake in one of Nigeria’s largest hard-rock lithium portfolios, backed by a A$1.6 million capital raise and a new working capital facility, marking a strategic move into the Africa–China lithium corridor.

Ioneer Ltd has dramatically expanded its lithium-boron Ore Reserves at Rhyolite Ridge, reinforcing the project’s robust economics and securing $16 million in new funding to advance development.

Peninsula Energy has completed a major reset of its uranium offtake contracts, terminating five of six agreements with a $6.6 million payout, while advancing commissioning of its Central Processing Plant toward first yellowcake production in Q3 2025.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Larvotto Resources has opened a $5 million Share Purchase Plan offering shares at a 13.5% discount to fund key development and exploration activities at its Hillgrove Project in NSW.

PlaySide Studios has raised $6.6 million through a share placement to bolster its balance sheet ahead of the launch of its new original game, MOUSE, P.I. For Hire. The capital raise includes director participation and an upcoming Share Purchase Plan for existing shareholders.

Clarity Pharmaceuticals has completed a $203 million institutional placement at a premium, bolstering its cash reserves to nearly $288 million and positioning the company to advance pivotal clinical trials and commercial preparations for its cancer-fighting radiopharmaceuticals.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.

Elsight Limited has responded to ASX concerns over a premature media report on its $60 million capital raise, denying any unauthorized disclosures and reaffirming its compliance with continuous disclosure rules.